Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $50.66
- 52-wk low
- $13.64
- Prev close
- $35.81
- Mkt cap
- $2.63B
- Fwd P/E
- 5000.0x
- Beta
- 1.14
Smart money
Earnings
Earnings came in $0.01 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $60.1M | $59.9M | $61.5M | $69.7M |
| Cost of what it sold | $14.1M | $15.5M | $15.3M | $19.1M |
| Gross profit | $46.0M | $44.4M | $46.2M | $50.7M |
| What it spent | ||||
| Research and development | $7.6M | $12.4M | $7.5M | $8.6M |
| Sales and admin | $10.8M | $14.6M | $12.9M | $13.4M |
| Other operating costs | $25.7M | $27.2M | $28.6M | $30.8M |
| Total operating expenses | $44.1M | $54.2M | $49.0M | $52.8M |
| What was left | ||||
| Operating profit | $1.9M | -$9.8M | -$2.8M | -$2.2M |
| Interest on debt | $10.2M | $1.7M | $694.0K | $1.0K |
| Profit before tax | $708.0K | -$13.2M | -$19.6M | -$1.5M |
| Net profit | $708.0K | -$13.2M | -$19.6M | -$1.5M |
| EBITDA | $12.6M | -$8.5M | -$16.8M | -$2.2M |
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage is bullish
Tone of tracked coverage
Axogen stock reaches 52-week high at 50.0 USD
NeutralAug 18Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN
Leans bullishAug 18689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC
Leans bullishAug 18